|
|
| (11) | Number of the document | C 1632232-2 |
| (68) | Number of the document | 1632232 |
| (21) | Application number for Supplementary Protection Certificate | PA 2016 043 |
| (22) | Date of filing the application | 2016-12-20 |
| (41) | Date of publication of the application | 2017-01-10 |
| Date of publication of SPC | 2024-09-10 | |
| (24) | Date of coming into effect of SPC | 2025-09-03 |
| (71) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/16/1112, 2016-06-21 |
| (94) | 2030-09-02 |
| (95) | Rilpivirino hidrochloridas ir tenofoviro alafenamidas |
| Payment date | Validity (years) | Amount | |
| 2025-08-04 | 1 | 347.00 EUR |
| 2026-09-03 |
| SPC granted |